Annual Working Capital
$143.27 M
-$119.95 M-45.57%
31 December 2023
Summary:
Catalyst Pharmaceuticals annual working capital is currently $143.27 million, with the most recent change of -$119.95 million (-45.57%) on 31 December 2023. During the last 3 years, it has risen by +$6.78 million (+4.97%). CPRX annual working capital is now -45.57% below its all-time high of $263.22 million, reached on 31 December 2022.CPRX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$433.60 M
+$51.49 M+13.48%
30 September 2024
Summary:
Catalyst Pharmaceuticals quarterly working capital is currently $433.60 million, with the most recent change of +$51.49 million (+13.48%) on 30 September 2024. Over the past year, it has increased by +$299.39 million (+223.08%). CPRX quarterly working capital is now at all-time high.CPRX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPRX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -45.6% | +223.1% |
| 3 y3 years | +5.0% | +151.8% |
| 5 y5 years | +213.7% | +497.3% |
CPRX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -45.6% | +5.0% | at high | +223.1% |
| 5 y | 5 years | -45.6% | +213.7% | at high | +497.3% |
| alltime | all time | -45.6% | >+9999.0% | at high | >+9999.0% |
Catalyst Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $433.60 M(+13.5%) |
| June 2024 | - | $382.11 M(+17.6%) |
| Mar 2024 | - | $325.04 M(+126.9%) |
| Dec 2023 | $143.27 M(-45.6%) | $143.27 M(+6.7%) |
| Sept 2023 | - | $134.21 M(-28.8%) |
| June 2023 | - | $188.47 M(+32.5%) |
| Mar 2023 | - | $142.20 M(-46.0%) |
| Dec 2022 | $263.22 M(+43.8%) | $263.22 M(+13.6%) |
| Sept 2022 | - | $231.63 M(+5.3%) |
| June 2022 | - | $220.07 M(+11.0%) |
| Mar 2022 | - | $198.25 M(+8.3%) |
| Dec 2021 | $183.04 M(+34.1%) | $183.04 M(+6.3%) |
| Sept 2021 | - | $172.18 M(+7.5%) |
| June 2021 | - | $160.17 M(+8.9%) |
| Mar 2021 | - | $147.10 M(+7.8%) |
| Dec 2020 | $136.49 M(+56.4%) | $136.49 M(+9.1%) |
| Sept 2020 | - | $125.11 M(+12.8%) |
| June 2020 | - | $110.95 M(+11.7%) |
| Mar 2020 | - | $99.31 M(+13.8%) |
| Dec 2019 | $87.26 M(+91.1%) | $87.26 M(+20.2%) |
| Sept 2019 | - | $72.60 M(+25.4%) |
| June 2019 | - | $57.90 M(+26.3%) |
| Mar 2019 | - | $45.84 M(+0.3%) |
| Dec 2018 | $45.68 M(-43.6%) | $45.68 M(-22.6%) |
| Sept 2018 | - | $59.01 M(-10.6%) |
| June 2018 | - | $66.00 M(-13.4%) |
| Mar 2018 | - | $76.20 M(-5.8%) |
| Dec 2017 | $80.92 M(+105.6%) | $80.92 M(+155.4%) |
| Sept 2017 | - | $31.68 M(-6.6%) |
| June 2017 | - | $33.91 M(-4.6%) |
| Mar 2017 | - | $35.55 M(-9.7%) |
| Dec 2016 | $39.36 M(-30.3%) | $39.36 M(-8.6%) |
| Sept 2016 | - | $43.06 M(-7.1%) |
| June 2016 | - | $46.37 M(-8.8%) |
| Mar 2016 | - | $50.81 M(-10.0%) |
| Dec 2015 | $56.46 M | $56.46 M(-8.9%) |
| Sept 2015 | - | $61.97 M(-5.7%) |
| June 2015 | - | $65.71 M(-6.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $70.12 M(+84.7%) |
| Dec 2014 | $37.97 M(+63.8%) | $37.97 M(-4.7%) |
| Sept 2014 | - | $39.83 M(-8.4%) |
| June 2014 | - | $43.49 M(+120.4%) |
| Mar 2014 | - | $19.73 M(-14.9%) |
| Dec 2013 | $23.18 M(+53.7%) | $23.18 M(-9.6%) |
| Sept 2013 | - | $25.63 M(+136.3%) |
| June 2013 | - | $10.85 M(-19.2%) |
| Mar 2013 | - | $13.42 M(-11.0%) |
| Dec 2012 | $15.08 M(+179.5%) | $15.08 M(+33.1%) |
| Sept 2012 | - | $11.33 M(+61.8%) |
| June 2012 | - | $7.00 M(+71.4%) |
| Mar 2012 | - | $4.09 M(-24.3%) |
| Dec 2011 | $5.39 M(-1.5%) | $5.39 M(+40.2%) |
| Sept 2011 | - | $3.85 M(-21.8%) |
| June 2011 | - | $4.92 M(-21.2%) |
| Mar 2011 | - | $6.24 M(+13.9%) |
| Dec 2010 | $5.48 M(-27.9%) | $5.48 M(-8.1%) |
| Sept 2010 | - | $5.96 M(+10.5%) |
| June 2010 | - | $5.39 M(-18.6%) |
| Mar 2010 | - | $6.63 M(-12.7%) |
| Dec 2009 | $7.59 M(-27.6%) | $7.59 M(+60.6%) |
| Sept 2009 | - | $4.73 M(-20.1%) |
| June 2009 | - | $5.92 M(-22.2%) |
| Mar 2009 | - | $7.61 M(-27.4%) |
| Dec 2008 | $10.49 M(-35.4%) | $10.49 M(-25.1%) |
| Sept 2008 | - | $14.00 M(+10.6%) |
| June 2008 | - | $12.66 M(-15.1%) |
| Mar 2008 | - | $14.90 M(-8.2%) |
| Dec 2007 | $16.23 M(-18.1%) | $16.23 M(-4.8%) |
| Sept 2007 | - | $17.04 M(-4.0%) |
| June 2007 | - | $17.76 M(-5.6%) |
| Mar 2007 | - | $18.81 M(-5.1%) |
| Dec 2006 | $19.82 M(+4523.2%) | $19.82 M(+754.0%) |
| Sept 2006 | - | $2.32 M(-2256.3%) |
| June 2006 | - | -$107.60 K(-125.1%) |
| Dec 2005 | $428.60 K(+269.2%) | $428.60 K(+269.2%) |
| Dec 2004 | $116.10 K | $116.10 K |
FAQ
- What is Catalyst Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual working capital year-on-year change?
- What is Catalyst Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly working capital year-on-year change?
What is Catalyst Pharmaceuticals annual working capital?
The current annual working capital of CPRX is $143.27 M
What is the all time high annual working capital for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual working capital is $263.22 M
What is Catalyst Pharmaceuticals annual working capital year-on-year change?
Over the past year, CPRX annual working capital has changed by -$119.95 M (-45.57%)
What is Catalyst Pharmaceuticals quarterly working capital?
The current quarterly working capital of CPRX is $433.60 M
What is the all time high quarterly working capital for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly working capital is $433.60 M
What is Catalyst Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, CPRX quarterly working capital has changed by +$299.39 M (+223.08%)